Get startedLog in
    Picture of Apontis Pharma AG logo

    APPH — Apontis Pharma AG News Story

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapHigh Flyer
    All News

    Brief: APONTIS PHARMA Launches Two New Single Pills

    Picture of Apontis Pharma AG logoApontis Pharma AG
    25/05/2022 06:33
    May 25 (Reuters) - APONTIS PHARMA AG  APPHG.DE :
    * POTENTIAL PATIENT GROUP OF 750,000 PEOPLE IN TOTAL
    * MEDIUM-TERM REVENUE POTENTIAL OF TONOTEC LIPID: EUR 5.0
MILLION
    * MEDIUM-TERM REVENUE POTENTIAL OF AMLOATOR: EUR 3.2 MILLION
    * LAUNCHES TWO NEW SINGLE PILLS - MEDIUM-TERM REVENUE
POTENTIAL OF
EUR 8.2 MILLION

Source text for Eikon:  ID:nEQ5HLl9ka 
Further company coverage:  APPHG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Apontis Pharma AG

    See all news